Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Molecular Cancer|June 26, 2023
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturingHyatt Balke-Want, Vimal Keerthi, Nikolaos Gkitsas, et al.
ACS Chemical Biology|December 27, 2014
Identification and further development of potent TBK1 inhibitorsAndré Richters, Debjit Basu, Julian Engel, et al.
Cell Reports. Medicine|January 21, 2026
c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumorsHyatt Balke-Want, Vimal Keerthi, Maria Del Carmen Arenas, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|March 5, 2002
Confessions of a managed behavioral health care physicianSteven A Feldman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2012
Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variantsJohannes M Heuckmann, Hyatt Balke-Want, Florian Malchers, et al.
Blood Advances|July 11, 2025
Sequential BCMA CAR-T Cell Therapy in Refractory Multiple MyelomaTim Richardson, Udo Holtick, Jan Hendrik Frenking, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
ALK mutations conferring differential resistance to structurally diverse ALK inhibitorsJohannes M Heuckmann, Michael Hölzel, Martin L Sos, et al.
Biochemical and Biophysical Research Communications|May 20, 2020
Ca2+-binding protein from Entamoeba histolytica (EhCaBP6) is a novel GTPaseDeepshikha Verma, Shalini Agarwal, Vimal Keerthi, et al.
Pageof 9